CompareCleerlyvsHeartFlow

Cleerly is an AI-driven coronary artery disease imaging platform for cardiology programs, analyzing coronary CT angiography to characterize plaque, stenosis, and atherosclerosis risk.

1. Clinical role: It supports cardiac imaging and risk stratification rather than autonomous cardiology, with cardiologist review remaining essential for every interpretation and related treatment decision.
2. Best-fit environment: Programs with strong coronary CT volumes may benefit most from its focus on plaque characterization and cardiovascular risk assessment.
3. Implementation checks: Buyers should assess regulatory clearance scope, imaging fit, reporting integration, clinical validation evidence, and workflow readiness before broader deployment.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, so teams should confirm service scope and support requirements.

A focused pilot can establish clinical workflow fit and implementation needs before a wider rollout.

HeartFlow is cardiovascular imaging AI for cardiology programs, creating personalized FFR-CT models from coronary CT scans to support coronary artery disease evaluation.

1. Clinical role: It supports cardiac imaging and risk stratification, not autonomous cardiology; cardiologist review of every interpretation remains essential for treatment and reporting decisions.
2. Operational fit: Programs managing coronary CT volumes may value its personalized FFR-CT modeling depth, although workflow changes are required to realize value.
3. Implementation checks: Buyers should confirm regulatory clearance scope, imaging modality fit, reporting integration, and clinical validation evidence before adoption across cardiology service lines.
4. Commercial considerations: Pricing is sales-led and scoped per buyer rather than publicly posted; verify EHR or workflow fit, scope, and support before committing.

HeartFlow suits programs prepared to integrate FFR-CT analysis into coronary CT workflows with oversight.